Incidence and severity of COVID-19 among vaccinated solid organ transplant recipients during the Omicron wave

JL Alejo, TPY Chiang, LB Zeiser, JD Kim… - …, 2022 - journals.lww.com
A total of 1801> 3×-vaccinated SOTRs from our national observational cohort were surveyed
about incident COVID-19 during the Omicron wave, of whom 1467 (81%) responded. A …

COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination

HM Wadei, TA Gonwa, JC Leoni, SZ Shah… - American journal of …, 2021 - amjtransplant.org
The prevalence and mortality of COVID-19 are higher in solid organ transplant recipients
(SOTs) compared to the general population. 1-3 Two SARS-CoV-2 messenger RNA (mRNA) …

[HTML][HTML] SARS-CoV-2 antibody testing for transplant recipients: a tool to personalize protection versus COVID-19

WA Werbel, DL Segev - American Journal of Transplantation, 2022 - Elsevier
Anti-spike antibody testing has emerged as a powerful tool to assess SARS-CoV-2 vaccine
response in solid organ transplant (SOT) recipients, many of whom remain at risk for COVID …

A fourth dose of COVID-19 vaccine does not induce neutralization of the omicron variant among solid organ transplant recipients with suboptimal vaccine response

AH Karaba, TS Johnston, TY Aytenfisu, O Akinde… - …, 2022 - journals.lww.com
Background. Humoral responses to coronavirus disease 2019 (COVID-19) vaccines are
attenuated in solid organ transplant recipients (SOTRs), necessitating additional booster …

Clinical characteristics of COVID‐19 in solid organ transplant recipients following COVID‐19 vaccination: A multicenter case series

KK Saharia, S Anjan, J Streit… - Transplant infectious …, 2022 - Wiley Online Library
Background Solid organ transplant recipients (SOTR) have diminished humoral immune
responses to COVID‐19 vaccination and higher rates of COVID‐19 vaccine breakthrough …

Severity of COVID-19 among solid organ transplant recipients in Canada, 2020–2021: a prospective, multicentre cohort study

VG Hall, JT Solera, G Al-Alahmadi, T Marinelli… - Cmaj, 2022 - Can Med Assoc
Background: Severe COVID-19 appears to disproportionately affect people who are
immunocompromised, although Canadian data in this context are limited. We sought to …

Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients

BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian… - Jama, 2021 - jamanetwork.com
Methods| Transplant recipients without prior polymerase chain reaction–confirmed COVID-
19 were recruited from across the US to participate in this prospective cohort through a …

SARS-CoV-2 messenger RNA vaccine immunogenicity in solid organ transplant recipients with prior COVID-19

BJ Boyarsky, I Barbur, TPY Chiang, MT Ou… - …, 2021 - journals.lww.com
BJB, IB, TP-YC, MTO, RSG, ATT, MRK, JIL, JMG-W., RKA, ABM, DLS, and WAW participated
in the conception or design of the work; or the acquisition, analysis, or interpretation of data …

Prospective clinical, virologic, and immunologic assessment of COVID-19 in transplant recipients

T Marinelli, VH Ferreira, M Ierullo, T Ku, L Lilly… - …, 2021 - journals.lww.com
Background. Several studies have described the clinical features of COVID-19 in solid-
organ transplant recipients. However, many have been retrospective or limited to more …

Early development and durability of SARS-CoV-2 antibodies among solid organ transplant recipients: a pilot study

BJ Boyarsky, MT Ou, WA Werbel, RK Avery… - …, 2021 - journals.lww.com
The immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
may be blunted in immunosuppressed individuals, impacting reinfection risk, treatment …